Citalopram and Finasteride by Greenstone Recalled due to Possible Mislabeling

Risk Manager, Pharmacy and Family Practice healthcare professionals are informed by the FDA that Citalopram and Finasteride by Greenstone are recalled because there is a possibility of mislabeling.

Background of Citalopram and Finasteride by Greenstone

Citalopram, by Greenstone LLC, is used to treat depression and Finasteride is used for the treatment of benign prostatic hyperplasia.

FDA Alert on Citalopram and Finasteride by Greenstone

FDA’s reason for the recall is that bottles labeled as Citalopram may contain Finasteride. Several severe side effects may occur to patients who discontinue Citalopram and women, who are or plan to become pregnant should not take Finasteride because it can cause abnormalities to the male fetus.

The affected drugs are Citalopram 10mg Tablets (100-count bottle) and Finasteride 5mg Tablets (90-count bottle).

Recommendation on Citalopram and Finasteride by Greenstone

“Bottles of either Citalopram or Finasteride with lot number FI0510058-A should be returned. Patients who believe they may have ingested the wrong medication should contact their physician as soon as possible.”

Contacting the FDA to report cases with Citalopram and Finasteride by Greenstone

In case of detection of adverse events or side effects related to the use of Citalopram and Finasteride by Greenstone, healthcare professionals and patients should report it to the FDA’s MedWatch Safety Information and Adverse Event Reporting program through any of the following ways:

The report can be completed and submitted Online at: www.fda.gov/MedWatch/report.htm

The form can be downloaded or requested by calling 1-800-332-1088, then completed and returned on the address indicated on the form

The completed form can be faxed to:  1-800-FDA-0178

AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.